Abiopharma

News list

Halladay Benjamin 🔴 sold 6.4K shares of Esperion Therapeutics, Inc. (ESPR) at $2.71 Transaction Date: Mar 17, 2026 | Filing ID: 019409

Full text

News bot March 18, 2026, 8:13 p.m.
🔍 Halladay Benjamin (Executive)

Company: Esperion Therapeutics, Inc. (ESPR)

Report Date: 2026-03-17
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 6,424
Detailed Transactions and Holdings:
- Sold 6,424 shares of Common Stock at $2.705 per share (Direct)
  Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 713,602.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Shares were sold to satisfy tax obligation on vested shares of restricted stock units.